Document is current
Any future updates will be listed below
-
Authors
McGuigan, Aisling https://orcid.org/0009-0009-7260-8131
- License Information
-
More Information
Article History
Received: 15 October 2025
Accepted: 12 January 2026
First Online: 22 January 2026
Declarations
:
: During the peer review process, the manufacturer of insulin aspart-szjj, Sanofi, was offered an opportunity to review this article. Changes resulting from comments received were made on the basis of scientific and editorial merit. A. McGuigan is a salaried employee of Adis International Ltd/Springer Nature, and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.
: Not applicable.
